Drug Information

Drug General Information
Drug ID
D08TVA
Former ID
DNC010891
Drug Name
MANIDIPINE
Drug Type
Small molecular drug
Indication Discovery agent Phase 3 [521680]
Structure
Download
2D MOL

3D MOL
Formula
C35H38N4O6
Canonical SMILES
CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC<br />=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC
InChI
1S/C35H38N4O6/c1-24-30(34(40)44-3)32(28-15-10-16-29(23-28)39(42)43)31(25(2)36-24)35(41)45-22-21-37-17-19-38(20-18-37)33(26-11-6-4-7-12-26)27-13-8-5-9-14-27/h4-16,23,32-33,36H,17-22H2,1-3H3
InChIKey
ANEBWFXPVPTEET-UHFFFAOYSA-N
CAS Number
CAS 89226-50-6
PubChem Compound ID
4008
SuperDrug ATC ID
C08CA11
Target and Pathway
Target(s) Cruzipain Target Info Inhibitor [530877]
References
Ref 521680ClinicalTrials.gov (NCT00157586) Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND). U.S. National Institutes of Health.
Ref 530877J Med Chem. 2010 May 27;53(10):4259-65.Colloid formation by drugs in simulated intestinal fluid.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.